Astellas Pharma Inc (Astellas) has acquired Universal Cells Inc for $102.5m.

The acquirer company is a pharmaceutical company based in the US, while the acquired company, also based in the US, is a biotech company.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

The acquisition will enable Astellas Pharma to use Universal Cells’ proprietary Universal Donor Cell technology to manufacture cell therapy products in a number of therapeutic areas.

Shenzhen Neptunus Bioengineering has agreed to acquire a 60% share in a medical tech company based in Tianjin for CNY48.6m ($7.69m).

The Chinese pharmaceutical company will complete the transaction through its Ningbo-based trade unit.

“Shenzhen Neptunus Bioengineering has agreed to acquire a 60% share in a medical tech company based in Tianjin for CNY48.6m ($7.69m).”

Mallinckrodt Pharmaceuticals has completed the acquisition of Sucampo Pharmaceuticals for $1.2bn.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The acquisition was announced in December 2017 and will add Sucampo’s AMITIZA (lubiprostone), RESCULA, VTS-270 and CPP-1X / sulindac products to Mallinckrodt’s portfolio.

Deutsche Bank was appointed as the financial advisor for the transaction by Mallinckrodt, and Wachtell, Lipton, Rosen & Katz as the legal advisor.

Jefferies served as the exclusive financial advisor for Sucampo and Cooley served as the legal advisor for the transaction.

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now